Graft versus host disease Trials in Seattle, United States
Conditions / Graft versus host disease / Seattle, United States
Graft versus host disease is a medical condition with active clinical research programs worldwide.
34 total trials for this combination
Showing top 10 of 34 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05263999 | A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR) | TERMINATED | PHASE3 |
| NCT00031824 | Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease | COMPLETED | PHASE3 |
| NCT00096096 | Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation | COMPLETED | PHASE2 |
| NCT01233921 | Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer | COMPLETED | NA |
| NCT00089037 | Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation | COMPLETED | PHASE1/PHASE2 |
| NCT00438958 | Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases | COMPLETED | PHASE3 |
| NCT00010283 | Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon | COMPLETED | PHASE1/PHASE2 |
| NCT00489203 | Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer | COMPLETED | PHASE2 |
| NCT00410657 | Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant | COMPLETED | PHASE2 |
| NCT00755040 | Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder | COMPLETED | PHASE3 |